EMAIL THIS PAGE TO A FRIEND

Journal of pharmaceutical and biomedical analysis

Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn.


PMID 21757313

Abstract

Lornoxicam was subjected to forced degradation studies under hydrolytic (acidic, basic and neutral), oxidative, photolytic and thermal stress conditions, as defined under ICH guideline Q1A (R2). The drug degraded significantly in hydrolytic, oxidative and photoneutral conditions, leading to the formation of eight degradation products in total. It was stable on exposure to light and dry heat in the solid state. The stressed samples in which degradation was observed were mixed together and used to develop a stability-indicating HPLC method wherein degradation products were separated from the drug and also from each other. To characterize the degradation products, a complete mass fragmentation pathway of the drug was first established with the help of MS/TOF, MS(n) and H/D exchange mass studies. The same was followed by LC-MS/TOF and on-line H/D exchange experiments on the degradation products. The degradation pathway of the drug was outlined, justified by the mechanisms of formation of the degradation products.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SML0338
Lornoxicam, ≥98% (HPLC)
C13H10ClN3O4S2